Financial incentive of home continuous positive airway pressure machine use in the inpatient hospital setting

David F. Smith, Charlene P. Spiceland, Lauren C. Pringle, Katie L. Mattare, James R. Benke, Stacey L. Ishman

Research output: Contribution to journalArticle

Abstract

Objectives/Hypothesis Obstructive sleep apnea (OSA) is increasingly recognized as a significant factor in perioperative and inpatient health. Because of this, hospitalized OSA patients are encouraged to utilize continuous positive airway pressure (CPAP) therapy while inpatients. We investigated the cost difference of patient-owned versus hospital-provided CPAP machine use by admitted adult patients with OSA. Study Design Prospective cohort study at a tertiary academic center. Methods All new-patient admissions >18 years of age who were prescribed CPAP while inpatients over a 2-month period were included. Demographic information was collected, and cost analysis was performed. Results CPAP was used for 162 (1.2%) admissions. Mean patient age was 59 ± 13 years; the majority were white (56.8%) and male (64.2%). Average CPAP utilization was 5.3 ± 5.5 nights. The differential cost per day for patients using hospital-provided CPAP was $416.10 more than for patients using home CPAP machines. This cost included direct costs of an extended respiratory therapy (RT) initial visit, machine rental fee ($27.50), and additional RT evaluation time (mean, 85-145 relative value units). The base initial visit was the same for all patients. Over the 2-month study period, the total cost difference in charges was $195,912; this extrapolates to $1,175,471 yearly. Conclusions This is the first study to characterize the magnitude of cost savings from utilization of home versus hospital-provided CPAP machines in patients requiring inpatient CPAP machine use. The use of patient-owned CPAP machines may reflect an opportunity to provide cheaper care while maintaining high patient safety and quality care. The actual economic impact to an individual hospital would vary based on the insurance payer mix. Level of Evidence 4

Original languageEnglish (US)
Pages (from-to)2200-2204
Number of pages5
JournalLaryngoscope
Volume124
Issue number9
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Continuous Positive Airway Pressure
Motivation
Inpatients
Costs and Cost Analysis
Obstructive Sleep Apnea
Respiratory Therapy
Fees and Charges
Cost Savings
Quality of Health Care
Patient Admission
Patient Safety
Insurance
Patient Care
Cohort Studies
Economics
Demography
Prospective Studies

Keywords

  • continuous positive airway pressure
  • cost analysis
  • cost effectiveness
  • Obstructive sleep apnea

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Smith, D. F., Spiceland, C. P., Pringle, L. C., Mattare, K. L., Benke, J. R., & Ishman, S. L. (2014). Financial incentive of home continuous positive airway pressure machine use in the inpatient hospital setting. Laryngoscope, 124(9), 2200-2204. https://doi.org/10.1002/lary.24604

Financial incentive of home continuous positive airway pressure machine use in the inpatient hospital setting. / Smith, David F.; Spiceland, Charlene P.; Pringle, Lauren C.; Mattare, Katie L.; Benke, James R.; Ishman, Stacey L.

In: Laryngoscope, Vol. 124, No. 9, 2014, p. 2200-2204.

Research output: Contribution to journalArticle

Smith, DF, Spiceland, CP, Pringle, LC, Mattare, KL, Benke, JR & Ishman, SL 2014, 'Financial incentive of home continuous positive airway pressure machine use in the inpatient hospital setting', Laryngoscope, vol. 124, no. 9, pp. 2200-2204. https://doi.org/10.1002/lary.24604
Smith, David F. ; Spiceland, Charlene P. ; Pringle, Lauren C. ; Mattare, Katie L. ; Benke, James R. ; Ishman, Stacey L. / Financial incentive of home continuous positive airway pressure machine use in the inpatient hospital setting. In: Laryngoscope. 2014 ; Vol. 124, No. 9. pp. 2200-2204.
@article{39c5d6a860234a7bb5ff15c5de22b016,
title = "Financial incentive of home continuous positive airway pressure machine use in the inpatient hospital setting",
abstract = "Objectives/Hypothesis Obstructive sleep apnea (OSA) is increasingly recognized as a significant factor in perioperative and inpatient health. Because of this, hospitalized OSA patients are encouraged to utilize continuous positive airway pressure (CPAP) therapy while inpatients. We investigated the cost difference of patient-owned versus hospital-provided CPAP machine use by admitted adult patients with OSA. Study Design Prospective cohort study at a tertiary academic center. Methods All new-patient admissions >18 years of age who were prescribed CPAP while inpatients over a 2-month period were included. Demographic information was collected, and cost analysis was performed. Results CPAP was used for 162 (1.2{\%}) admissions. Mean patient age was 59 ± 13 years; the majority were white (56.8{\%}) and male (64.2{\%}). Average CPAP utilization was 5.3 ± 5.5 nights. The differential cost per day for patients using hospital-provided CPAP was $416.10 more than for patients using home CPAP machines. This cost included direct costs of an extended respiratory therapy (RT) initial visit, machine rental fee ($27.50), and additional RT evaluation time (mean, 85-145 relative value units). The base initial visit was the same for all patients. Over the 2-month study period, the total cost difference in charges was $195,912; this extrapolates to $1,175,471 yearly. Conclusions This is the first study to characterize the magnitude of cost savings from utilization of home versus hospital-provided CPAP machines in patients requiring inpatient CPAP machine use. The use of patient-owned CPAP machines may reflect an opportunity to provide cheaper care while maintaining high patient safety and quality care. The actual economic impact to an individual hospital would vary based on the insurance payer mix. Level of Evidence 4",
keywords = "continuous positive airway pressure, cost analysis, cost effectiveness, Obstructive sleep apnea",
author = "Smith, {David F.} and Spiceland, {Charlene P.} and Pringle, {Lauren C.} and Mattare, {Katie L.} and Benke, {James R.} and Ishman, {Stacey L.}",
year = "2014",
doi = "10.1002/lary.24604",
language = "English (US)",
volume = "124",
pages = "2200--2204",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Financial incentive of home continuous positive airway pressure machine use in the inpatient hospital setting

AU - Smith, David F.

AU - Spiceland, Charlene P.

AU - Pringle, Lauren C.

AU - Mattare, Katie L.

AU - Benke, James R.

AU - Ishman, Stacey L.

PY - 2014

Y1 - 2014

N2 - Objectives/Hypothesis Obstructive sleep apnea (OSA) is increasingly recognized as a significant factor in perioperative and inpatient health. Because of this, hospitalized OSA patients are encouraged to utilize continuous positive airway pressure (CPAP) therapy while inpatients. We investigated the cost difference of patient-owned versus hospital-provided CPAP machine use by admitted adult patients with OSA. Study Design Prospective cohort study at a tertiary academic center. Methods All new-patient admissions >18 years of age who were prescribed CPAP while inpatients over a 2-month period were included. Demographic information was collected, and cost analysis was performed. Results CPAP was used for 162 (1.2%) admissions. Mean patient age was 59 ± 13 years; the majority were white (56.8%) and male (64.2%). Average CPAP utilization was 5.3 ± 5.5 nights. The differential cost per day for patients using hospital-provided CPAP was $416.10 more than for patients using home CPAP machines. This cost included direct costs of an extended respiratory therapy (RT) initial visit, machine rental fee ($27.50), and additional RT evaluation time (mean, 85-145 relative value units). The base initial visit was the same for all patients. Over the 2-month study period, the total cost difference in charges was $195,912; this extrapolates to $1,175,471 yearly. Conclusions This is the first study to characterize the magnitude of cost savings from utilization of home versus hospital-provided CPAP machines in patients requiring inpatient CPAP machine use. The use of patient-owned CPAP machines may reflect an opportunity to provide cheaper care while maintaining high patient safety and quality care. The actual economic impact to an individual hospital would vary based on the insurance payer mix. Level of Evidence 4

AB - Objectives/Hypothesis Obstructive sleep apnea (OSA) is increasingly recognized as a significant factor in perioperative and inpatient health. Because of this, hospitalized OSA patients are encouraged to utilize continuous positive airway pressure (CPAP) therapy while inpatients. We investigated the cost difference of patient-owned versus hospital-provided CPAP machine use by admitted adult patients with OSA. Study Design Prospective cohort study at a tertiary academic center. Methods All new-patient admissions >18 years of age who were prescribed CPAP while inpatients over a 2-month period were included. Demographic information was collected, and cost analysis was performed. Results CPAP was used for 162 (1.2%) admissions. Mean patient age was 59 ± 13 years; the majority were white (56.8%) and male (64.2%). Average CPAP utilization was 5.3 ± 5.5 nights. The differential cost per day for patients using hospital-provided CPAP was $416.10 more than for patients using home CPAP machines. This cost included direct costs of an extended respiratory therapy (RT) initial visit, machine rental fee ($27.50), and additional RT evaluation time (mean, 85-145 relative value units). The base initial visit was the same for all patients. Over the 2-month study period, the total cost difference in charges was $195,912; this extrapolates to $1,175,471 yearly. Conclusions This is the first study to characterize the magnitude of cost savings from utilization of home versus hospital-provided CPAP machines in patients requiring inpatient CPAP machine use. The use of patient-owned CPAP machines may reflect an opportunity to provide cheaper care while maintaining high patient safety and quality care. The actual economic impact to an individual hospital would vary based on the insurance payer mix. Level of Evidence 4

KW - continuous positive airway pressure

KW - cost analysis

KW - cost effectiveness

KW - Obstructive sleep apnea

UR - http://www.scopus.com/inward/record.url?scp=84906936141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906936141&partnerID=8YFLogxK

U2 - 10.1002/lary.24604

DO - 10.1002/lary.24604

M3 - Article

C2 - 24448722

AN - SCOPUS:84906936141

VL - 124

SP - 2200

EP - 2204

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 9

ER -